Elucidating the specific pharmacological mechanism of motion (MOA) of naturally developing compounds is often complicated. Although Tarselli et al. (60) developed the first de novo artificial pathway to conolidine and showcased that this By natural means taking place compound properly suppresses responses to each chemically induced and inflammation